WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.55 Billion CNY | -5.94% |
| 2022 | 13.35 Billion CNY | 17.88% |
| 2021 | 11.32 Billion CNY | 40.45% |
| 2020 | 8.06 Billion CNY | 71.35% |
| 2019 | 4.7 Billion CNY | 236.41% |
| 2018 | 1.39 Billion CNY | 69.65% |
| 2017 | 824.6 Million CNY | -51.91% |
| 2016 | 1.71 Billion CNY | 41.61% |
| 2015 | 1.21 Billion CNY | 357.15% |
| 2014 | 264.84 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 11.46 Billion CNY | 0.0% |
| 2023 Q4 | 12.55 Billion CNY | 0.0% |
| 2023 FY | 12.55 Billion CNY | -5.94% |
| 2023 Q2 | 13.09 Billion CNY | 0.0% |
| 2022 Q2 | 11.99 Billion CNY | 0.0% |
| 2022 Q4 | 13.35 Billion CNY | 0.0% |
| 2022 FY | 13.35 Billion CNY | 17.88% |
| 2021 FY | 11.32 Billion CNY | 40.45% |
| 2021 Q4 | 11.32 Billion CNY | 0.0% |
| 2021 Q2 | 9.99 Billion CNY | 0.0% |
| 2020 Q2 | 6.94 Billion CNY | 0.0% |
| 2020 FY | 8.06 Billion CNY | 71.35% |
| 2020 Q4 | 8.06 Billion CNY | 0.0% |
| 2019 Q4 | 4.7 Billion CNY | 0.0% |
| 2019 FY | 4.7 Billion CNY | 236.41% |
| 2019 Q2 | 1.66 Billion CNY | 0.0% |
| 2018 Q4 | 1.39 Billion CNY | 0.0% |
| 2018 Q2 | 1.05 Billion CNY | 0.0% |
| 2018 FY | 1.39 Billion CNY | 69.65% |
| 2017 Q2 | 1.8 Billion CNY | 0.0% |
| 2017 Q4 | 824.6 Million CNY | 0.0% |
| 2017 FY | 824.6 Million CNY | -51.91% |
| 2016 Q4 | 1.71 Billion CNY | 0.0% |
| 2016 FY | 1.71 Billion CNY | 41.61% |
| 2015 Q2 | 302.67 Million CNY | 0.0% |
| 2015 Q1 | 302.67 Million CNY | 357.15% |
| 2015 Q4 | 302.67 Million CNY | 0.0% |
| 2015 FY | 1.21 Billion CNY | 357.15% |
| 2015 Q3 | 302.67 Million CNY | 0.0% |
| 2014 Q3 | 66.21 Million CNY | 0.0% |
| 2014 Q4 | 66.21 Million CNY | 0.0% |
| 2014 FY | 264.84 Million CNY | 0.0% |
| 2014 Q1 | 66.21 Million CNY | 0.0% |
| 2014 Q2 | 66.21 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | -23458.473% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -130956.305% |
| SQZ Biotechnologies Company | 50.03 Million USD | -24996.113% |
| Evofem Biosciences, Inc. | 72.47 Million USD | -17228.095% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | -21179.414% |
| Mesoblast Limited | 188.44 Million USD | -6563.944% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -325957.167% |
| Genus plc | 485 Million USD | -2489.246% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -214835.112% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -498954.336% |
| Marizyme, Inc. | 26.67 Million USD | -46975.949% |
| ContraFect Corporation | 32.53 Million USD | -38502.699% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -330369.579% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -633715.843% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -327982.52% |
| Intellipharmaceutics International Inc. | 12 Million USD | -104472.301% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -106519.427% |
| MultiCell Technologies, Inc. | 1617.67 USD | -776291974.403% |
| Accustem Sciences Inc. | 1.07 Million USD | -1163483.229% |
| RVL Pharmaceuticals plc | 77.41 Million USD | -16121.042% |
| EV Biologics, Inc. | 2.11 Million USD | -593632.119% |
| Q BioMed Inc. | 8.13 Million USD | -154307.208% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | -15041.791% |
| Neon Bloom, Inc. | 1.22 Million USD | -1024016.039% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -243929.51% |
| Biomind Labs Inc. | 1.49 Million USD | -837864.997% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 244.07 Million USD | -5045.118% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -68136.488% |
| Skye Bioscience, Inc. | 14.07 Million USD | -89138.485% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -624627.953% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -8837539.607% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -132563.731% |
| IMV Inc. | 37.93 Million USD | -33005.508% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -6243980.033% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -218456.13% |
| GB Sciences, Inc. | 5.41 Million USD | -231699.019% |
| Alpha Cognition Inc. | 7.16 Million USD | -175172.018% |
| HST Global, Inc. | 593.59 Thousand USD | -2115464.705% |
| CSL Limited | 18.62 Billion USD | 32.561% |
| Halberd Corporation | 728.71 Thousand USD | -1723176.599% |
| Enzolytics Inc. | 365.26 Million USD | -3337.971% |
| Resverlogix Corp. | 67.39 Million USD | -18532.922% |
| Affymax, Inc. | 8.87 Million USD | -141460.636% |
| SYBLEU INC | 681.41 Thousand USD | -1842812.301% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -1497141.55% |
| argenx SE | 444.95 Million USD | -2722.298% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | -16661.671% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -732563.011% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -105400.609% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -342527.069% |
| AVAX Technologies, Inc. | 3.99 Million USD | -314337.802% |
| Zenith Capital Corp. | 27.56 Thousand USD | -45550496.685% |
| Genscript Biotech Corporation | 1.32 Billion USD | -847.138% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -5261845.746% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -336183.208% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -1844379.565% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | -10477.501% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -138780.497% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -18762833.855% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -875706.232% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | -24883.774% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -463008.649% |
| BioStem Technologies, Inc. | 15.9 Million USD | -78856.975% |
| ONE Bio Corp. | 27.49 Million USD | -45571.846% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -2702260.883% |
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -45776315.266% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -997193.028% |
| Agentix Corp. | 2.51 Million USD | -500101.908% |
| LadRx Corporation | 2.2 Million USD | -570574.129% |
| Cell Source, Inc. | 15.8 Million USD | -79346.266% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -28096024.933% |
| Regen BioPharma, Inc. | 5.45 Million USD | -229997.61% |
| Regen BioPharma, Inc. | 5.45 Million USD | -229997.61% |
| NovAccess Global Inc. | 7.86 Million USD | -159654.13% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -50646.91% |
| Itoco Inc. | 1.65 Million USD | -759530.79% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -612010.462% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -207501.984% |
| Kadimastem Ltd | 3.5 Million USD | -358197.305% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -2978741.848% |
| CytoDyn Inc. | 127.89 Million USD | -9718.947% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -30043307.737% |
| Mobile Lads Corp. | 1.31 Million USD | -955961.871% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -801612.742% |
| Qrons Inc. | 1.48 Million USD | -843436.934% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -113594.119% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -1552562.854% |
| Rebus Holdings, Inc. | 5.24 Million USD | -239462.076% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -205702.024% |
| International Stem Cell Corporation | 5.27 Million USD | -237873.167% |
| Bioxytran, Inc. | 3.24 Million USD | -386354.655% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -2006557.622% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -271884.059% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | -30531.876% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -56301.725% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -619921.951% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -229141.402% |
| Neutra Corp. | 973.52 Thousand USD | -1289830.141% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -43180.524% |
| PureTech Health plc | 125.58 Million USD | -9899.637% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -334140.783% |
| IXICO plc | 1.9 Million USD | -660737.598% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -61071.241% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -12053.85% |
| CSL Limited | 18.62 Billion USD | 32.561% |
| Cellectis S.A. | 249.36 Million USD | -4935.84% |